The results showed that a much higher level of γ-H2AX foci appears in GBM cells treated with overexpression of miR-124 plus TMZ in comparison with miR-ctrl plus TMZ (Fig. 4E, F). The gene discussed is H2AX; the disease is glioblastoma.